Search

Armata Pharmaceuticals has announced a $35 million credit agreement with its largest shareholder, Innoviva.

The UK government has responded to the Science, Innovation, and Technology Committee's report on the antimicrobial potential of phages, outlining recommendations for assessing the safety and effectiveness of phages in healthcare settings.

Owen Tuck and colleagues have discovered the Hachiman defense system, a broad-spectrum antiphage defense system, activates in response to DNA damage, creating 'phantom' cells devoid of both phage and host DNA. Preprint | Tweet thread

Attention phage researchers! The Felix d'Herelle Center is calling for deposits of characterized phages to ensure permanent archiving and prevent loss when research projects end. Have you considered depositing your lab's collection?

This week on PhageCast, the team talked to Paul Turner about how his lab is predicting the trade-offs of bacterial resistance to phage, to achieve killing by reversing the antibiotic resistance. They also covered how these findings are tran

The International Society of Microbiota will host their 11th Annual Meeting, Targeting Microbiota, on October 17-18 at the Corinthia Palace Malta, to explore the role of microbiota in health and disease, advancements in microbiome medicine,

Pherecydes has a new phage therapy patent. It covers new S. aureus phages and their manufacture and combination for use in phage therapy and as a companion diagnostic.

NIAID seeks applications from single institutions or consortia ready to generate, validate, and advance medical countermeasures against drug-resistant bacteria or fungi.

Nicholas Smith (University at Buffalo) and colleagues published a new paper exploring the pharmacodynamics of three unique Pseudomonas phages by simulating different dosing strategies (cocktails vs. single phage, bolus vs. prolonged dosing)

Ana Rita Costa (Delft University of Technology) and colleagues published a new paper showing that clinical P. aeruginosa strains accumulate phage defense systems (some have at least 19!), that many individual defense systems target specific

Ritu Arora (University of Delhi) and colleagues isolated 100+ mycobacteriophages over the last two years, and here announce five genomes from different clusters, infecting M. tuberculosis and M. fortuitum.

PhageCast recently interviewed Lorenzo Corsini about why Staph phages don’t work well in plasma or synovial fluid, and talked to Jean-Paul Pirnay (2-part series) about the Queen Astrid Military Hospital’s first 100 documented cases of phage

Greg German (Unity Health Toronto) has been awarded a Professorship at the University of Toronto for Bacteriophage Research and Innovation with a five year term. Congrats Greg!

In an article featured in BioSpectrum India, Atif Khan, a scientist at the Biofouling and Biofilm Processes Section of the Bhabha Atomic Research Centre, India discusses the likely establishment of phage infrastructure in India within the n

Michael Shamash, a gut phageome PhD student at McGill University, explores the influence of gut phages on the human microbiome and their potential impact on health in a podcast interview with Justine Dees at the Joyful Microbe.

Hugo Oliveira (University of Minho) will share insights from in vitro and in vivo studies on a phage-derived protein on February 29th at 11 AM GMT as part of the Africa Phage Forum series. Register here.

Only 4 months remain until the Viruses of Microbes 2024 Meeting takes place (July 15-19, 2024). Phage researchers are encouraged to confirm their participation early to plan for the trip down under!

From David Bikard via Twitter: A question to the phage aficionado. Do you have clear examples of anti-phage defense systems that block the production or assembly of phage particles without targeting the phage DNA and without resulting in ce

Dear phage researchers, for receptor-binding experiments, we are looking for phage T2. If anyone is still actively working with T2, we'd appreciate a small sample. With best wishes, Mark van Raaij, mjvanraaij@cnb.csic.es

Dear researchers and Professors: This is a small bio-technology company in China. We urgently need to buy or share some Streptococcus mutant phage M102, M102AD, e10, f1, SMHBZ8, APCM01, phiKSM96, to continue our research, If you got some or